TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan gets FDA approval of blood pressure drug

About Alex Nixon

By Alex Nixon

Published: Tuesday, Nov. 13, 2012, 10:34 a.m.

Mylan Inc. said on Tuesday that it gained Food and Drug Administration approval for a generic blood pressure drug.

Cecil-based Mylan said it has started shipping Sildenafil Citrate tablets, the generic version of Pfizer Inc.'s Revatio.

Revatio had U.S. sales of $338.7 million in the 12 months ended Sept. 30.

Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or anixon@tribweb.com.

 

 

 
 


Show commenting policy

Most-Read Business

Subscribe today! Click here for our subscription offers.